Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Arpinati

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
BMC Developmental Biology|February 23, 2007
Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitroFrancesco Alviano, Valentina Fossati, Cosetta Marchionni, et al.
Bone Marrow Transplantation|September 21, 2018
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective studyFrancesca Bonifazi, Elisa Dan, Myriam Labopin, et al.
Haematologica|December 7, 2007
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II StudyPier Paolo Piccaluga, Michele Malagola, Michela Rondoni, et al.
Frontiers in Immunology|January 30, 2023
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patientsGianluca Storci, Francesco Barbato, Francesca Ricci, et al.
Transplantation and Cellular Therapy|August 17, 2021
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell TransplantationMario Delia, Paola Carluccio, Anna Mestice, et al.
Frontiers in Oncology|October 24, 2022
The <i>ALLgorithMM</i>: How to define the hemodilution of bone marrow samples in lymphoproliferative diseasesIlaria Vigliotta, Silvia Armuzzi, Martina Barone, et al.
Frontiers in Immunology|February 2, 2023
Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicitySerena De Matteis, Michele Dicataldo, Beatrice Casadei, et al.
Bone Marrow Transplantation|November 27, 2019
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myelomaGiulia Tolomelli, Katia Mancuso, Paola Tacchetti, et al.
Frontiers in Immunology|February 17, 2022
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still MattersSarah Parisi, Loredana Ruggeri, Elisa Dan, et al.
Journal of Translational Medicine|August 7, 2019
Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their functionFrancesca Ulbar, Tiziana Montemurro, Tatiana Jofra, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
BMC Developmental Biology|February 23, 2007
Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitroFrancesco Alviano, Valentina Fossati, Cosetta Marchionni, et al.
Bone Marrow Transplantation|September 21, 2018
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective studyFrancesca Bonifazi, Elisa Dan, Myriam Labopin, et al.
Haematologica|December 7, 2007
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II StudyPier Paolo Piccaluga, Michele Malagola, Michela Rondoni, et al.
Frontiers in Immunology|January 30, 2023
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patientsGianluca Storci, Francesco Barbato, Francesca Ricci, et al.
Transplantation and Cellular Therapy|August 17, 2021
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell TransplantationMario Delia, Paola Carluccio, Anna Mestice, et al.
Frontiers in Oncology|October 24, 2022
The <i>ALLgorithMM</i>: How to define the hemodilution of bone marrow samples in lymphoproliferative diseasesIlaria Vigliotta, Silvia Armuzzi, Martina Barone, et al.
Frontiers in Immunology|February 2, 2023
Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicitySerena De Matteis, Michele Dicataldo, Beatrice Casadei, et al.
Bone Marrow Transplantation|November 27, 2019
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myelomaGiulia Tolomelli, Katia Mancuso, Paola Tacchetti, et al.
Frontiers in Immunology|February 17, 2022
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still MattersSarah Parisi, Loredana Ruggeri, Elisa Dan, et al.
Journal of Translational Medicine|August 7, 2019
Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their functionFrancesca Ulbar, Tiziana Montemurro, Tatiana Jofra, et al.
Pageof 6